IntelliAM AI PLC - New Purchase Orders from Mars UK
Announcement provided by
IntelliAM AI Plc · INT22/07/2026 07:00
22 July 2026
Expansion of Mars UK Relationship to Six Sites
£425,000 of orders secured, including £334,000 of revenue for the current financial year
IntelliAM AI plc (AQSE: INT), the industrial software company applying artificial intelligence and machine learning to improve the productivity, reliability and sustainability of manufacturing operations, is pleased to announce the further expansion of its relationship with Mars
The latest contract order extends IntelliAM's work across Mars
· Mars Chocolate;
· Mars Horsecare;
· Mars Care & Treats, part of Mars Petcare;
· the Waltham Petcare Science Institute;
· James Wellbeloved, part of Royal Canin; and
· Wrigley.
The engagement covers the provision of IntelliAM's specialist asset-management and reliability services, together with the deployment of the Company's IntelliAM Layer 1 software across
Following the latest order, the total value of Mars
These figures represent the minimum level of contracted work currently secured and do not include any additional orders that may be placed during the remainder of the financial year.
Tom Clayton, Chief Executive Officer of IntelliAM, commented:
"The expansion of our relationship with Mars
"Mars operates some of the best-known consumer and petcare brands in the world, and we are delighted that Wrigley has now joined the growing number of Mars
"With these orders now secured, including
Enquiries:
Investor questions on this announcement
We encourage all investors to share questions on this announcement via our investor hub: https://investors.intelliam.ai/link/eXgD4y
IntelliAM AI plc
Tom Clayton, Chief Executive Officer
Daud Khan, Chief Financial Officer
+44 114 299 5007
Cavendish Capital Markets Limited - AQSE Corporate Adviser and Broker
Giles Balleny/Elysia Bough
+44 20 7220 0500
Square1 Consulting - Financial PR
David Bick
+44 7831 381201
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.